1
MEETING ABSTRACT Open Access Biological theory of depression in the light of new evidence George Papageorgiou From 1 st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance Thessaloniki, Greece. 19-22 November 2009 The finding of various structural and chemical abnorm- alities in the brain through neuroimaging has been the mainstay in depression research the last few years. Research isnt necessarily focused in a specific area of the brain, bur rather combines the pathophysiology of neurochemical communication of various brain areas to specific symptoms. The functionality of various brain areas, such as the prefrontal cortex or the amygdale or nucleus accumbens is theoretically linked with diverse symptom constellations. This might lead to more sophisticated treatment methods. New data on the func- tion of the HPA axis and the role of CRF in stress response, contribute to the further understanding to the neurobiology of depression. As for the present therapeu- tic implications, the monoaminergic theory of depres- sion is paralleled with the chronobiolgy theory and mainly with the theory of circadian rhythm dysregula- tion. All of the above lead to the rationale of the correct choice of antidepressants. Published: 22 April 2010 References 1. Drevets WC: Neuroimaging studies of mood disorders. Biol Psychiatry 2000, 48:813-829. 2. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM: Neurobiology of depression. Neuron 2002, 34:13-25. 3. Stahl SM: Stahls Essential Psychopharmacology. Neuroscientific Basis and Practical Applications Cambridge Univ. Press, New York, NY, 3 2008. doi:10.1186/1744-859X-9-S1-S47 Cite this article as: Papageorgiou: Biological theory of depression in the light of new evidence. Annals of General Psychiatry 2010 9(Suppl 1):S47. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit Department of Psychiatry, Evangelismos Hospital, Athens Greece Papageorgiou Annals of General Psychiatry 2010, 9(Suppl 1):S47 http://www.annals-general-psychiatry.com/content/9/S1/S47 © 2009 Papageorgiou; licensee BioMed Central Ltd.

Biological theory of depression in the light of new evidence

Embed Size (px)

Citation preview

Page 1: Biological theory of depression in the light of new evidence

MEETING ABSTRACT Open Access

Biological theory of depression in the light ofnew evidenceGeorge Papageorgiou

From 1st International Congress on Neurobiology and Clinical Psychopharmacology and EuropeanPsychiatric Association Conference on Treatment GuidanceThessaloniki, Greece. 19-22 November 2009

The finding of various structural and chemical abnorm-alities in the brain through neuroimaging has been themainstay in depression research the last few years.Research isn’t necessarily focused in a specific area ofthe brain, bur rather combines the pathophysiology ofneurochemical communication of various brain areas tospecific symptoms. The functionality of various brainareas, such as the prefrontal cortex or the amygdale ornucleus accumbens is theoretically linked with diversesymptom constellations. This might lead to moresophisticated treatment methods. New data on the func-tion of the HPA axis and the role of CRF in stressresponse, contribute to the further understanding to theneurobiology of depression. As for the present therapeu-tic implications, the monoaminergic theory of depres-sion is paralleled with the chronobiolgy theory andmainly with the theory of circadian rhythm dysregula-tion. All of the above lead to the rationale of the correctchoice of antidepressants.

Published: 22 April 2010

References1. Drevets WC: Neuroimaging studies of mood disorders. Biol Psychiatry

2000, 48:813-829.2. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM:

Neurobiology of depression. Neuron 2002, 34:13-25.3. Stahl SM: Stahl’s Essential Psychopharmacology. Neuroscientific Basis and

Practical Applications Cambridge Univ. Press, New York, NY, 3 2008.

doi:10.1186/1744-859X-9-S1-S47Cite this article as: Papageorgiou: Biological theory of depression in thelight of new evidence. Annals of General Psychiatry 2010 9(Suppl 1):S47.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

Department of Psychiatry, Evangelismos Hospital, Athens Greece

Papageorgiou Annals of General Psychiatry 2010, 9(Suppl 1):S47http://www.annals-general-psychiatry.com/content/9/S1/S47

© 2009 Papageorgiou; licensee BioMed Central Ltd.